Bioregenx (BRGX) EBITDA Margin (2022 - 2026)
Bioregenx (BRGX) recorded quarterly EBITDA Margin of 6.2% in Q1 2026, up 97.65% quarter-over-quarter from 263.93% in Q4 2025, and up 4600.0% on a YoY basis from 0.13% in Q1 2025.
Bioregenx (BRGX) EBITDA Margin (2022 - 2026) Analysis & Trends
Bioregenx's EBITDA Margin history runs 5 years deep, the most recent figure standing at 6.2% for Q1 2026.
- In Q1 2026, EBITDA Margin rose 4600.0% year-over-year to 6.2%; the TTM figure through Mar 2026 stood at 73.81% (up 80092.0% YoY), while the FY2025 annual figure was 83.34%, up 90170.0% from the prior year.
- EBITDA Margin was 6.2% for Q1 2026 at Bioregenx, up from 263.93% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 161.38% in Q3 2022 to a low of 3995.01% in Q4 2024.
- Historically, EBITDA Margin has averaged 383.7% across 5 years, with a median of 66.68% in 2024.
- The sharpest annual moves came in 2024 and 2025: EBITDA Margin sank 395701 bps in 2024, then soared 373109 bps in 2025.
- A 5-year view of EBITDA Margin shows it stood at 62.09% in 2022, then surged by 39 bps to 38.01% in 2023, then sank by 10411 bps to 3995.01% in 2024, then soared by 93 bps to 263.93% in 2025, then surged by 98 bps to 6.2% in 2026.
- The last three EBITDA Margin figures came in at 6.2% (Q1 2026), 263.93% (Q4 2025), and 14.44% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 26.39% |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 3.36% |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 29.03% |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 19.09% |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | -11.30% |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 17.08% |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 27.87% |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 1.25% |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 5.44% |
| 10 | Bioregenx | - | - | 348,288.00 | -6.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.20% |
| Dec 31, 2025 | -263.93% |
| Sep 30, 2025 | -14.44% |
| Jun 30, 2025 | -41.60% |
| Mar 31, 2025 | -52.20% |
| Dec 31, 2024 | -3,995.01% |
| Sep 30, 2024 | -66.68% |
| Jun 30, 2024 | -150.62% |
| Mar 31, 2024 | -573.46% |
| Dec 31, 2023 | -38.01% |
| Sep 30, 2023 | -317.04% |
| Jun 30, 2023 | -67.13% |
| Mar 31, 2023 | -20.92% |
| Dec 31, 2022 | -62.09% |
| Sep 30, 2022 | 161.38% |
| Jun 30, 2022 | -790.17% |
| Mar 31, 2022 | -224.81% |